Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 676 AL 690

Insulin resistance, type 2 diabetes, and AD: cerebrovascular disease or neurodegeneration?

Luchsinger JA.

Neurology. 2010 Aug 31;75(9):758-9. doi: 10.1212/WNL.0b013e3181eee287. Epub 2010 Aug 25.

Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators

Bhat NR.

J Neurochem. 2010 Nov;115(3):551-62. doi: 10.1111/j.1471-4159.2010.06978.x. Epub 2010 Sep 28.

Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease

Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, Canonico V, Trequattrini A, Pettenati C, Caltagirone C, Palmer K.

Am J Geriatr Psychiatry. 2010 Nov;18(11):1026-35. doi: 10.1097/JGP.0b013e3181d6b68d.

Overview of Chinese research on senile dementia in mainland China

Song Y, Wang J.

Ageing Res Rev. 2010 Nov;9 Suppl 1:S6-12. doi: 10.1016/j.arr.2010.08.007. Epub 2010 Sep 8.

Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients

Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S, Katsinelos P, Grigoriadis N, Giartza-Taxidou E, Venizelos I.

Cogn Behav Neurol. 2010 Sep;23(3):199-204. doi: 10.1097/WNN.0b013e3181df3034.

ACS chemical neuroscience molecule spotlight on dimebon

Hopkins CR.

ACS Chem Neurosci. 2010 Sep 15;1(9):587-8. doi: 10.1021/cn1000588.

How does diabetes accelerate Alzheimer disease pathology?

Sims-Robinson C, Kim B, Rosko A, Feldman EL.

Nat Rev Neurol. 2010 Oct;6(10):551-9. doi: 10.1038/nrneurol.2010.130. Epub 2010 Sep 14.

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fiévet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alpérovitch A, Ruiz A, Kamboh MI, Amouyel P.

J Alzheimers Dis. 2010;22(1):247-55. doi: 10.3233/JAD-2010-100933.

Functional assessment staging (FAST) in Korean patients with Alzheimer's disease

Na HR, Kim SY, Chang YH, Park MH, Cho ST, Han IW, Kim TY, Hwang SA.

J Alzheimers Dis. 2010;22(1):151-8. doi: 10.3233/JAD-2010-100072.

Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study

Agüera-Ortiz L, Frank-García A, Gil P, Moreno A; 5E Study Group.

Int Psychogeriatr. 2010 Dec;22(8):1265-79. doi: 10.1017/S104161021000150X. Epub 2010 Sep 20.

[Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations]

Golenkina SA, Gol'tsov AIu, Kuznetsova IL, Grigorenko AP, Andreeva TV, Reshetov DA, Kunizheva SS, Shagam LI, Morozova IIu, Goldenkova-Pavlova IV, Shimshilashvili Kh, Viacheslavova AO, Faskhutdinova G, Gareeva AÉ, Zaĭnullina AG, Khusnutdinova ÉK, Puzyrev VP, Stepanov VA, Kolotvin AV, Samokhodskaia LM, Selezneva ND, Gavrilova SI, Rogaev EI.

Mol Biol (Mosk). 2010 Jul-Aug;44(4):620-6.

Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment

Fernández M, Gobartt AL, Balañá M; COOPERA Study Group.

BMC Neurol. 2010 Sep 28;10:87. doi: 10.1186/1471-2377-10-87.

Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease

Whitehouse IJ, Jackson C, Turner AJ, Hooper NM.

J Alzheimers Dis. 2010;22(3):1023-31. doi: 10.3233/JAD-2010-101071.

Alzheimer disease: update on basic mechanisms

Bi X.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S3-9.

Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project

Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, Hendler T, Hermann B, Inzelberg R, Johnson S, Khachaturian ZS, Lichter-Shapira I, Makeeva O, Mayrl R, Mizrahi E, Roses AD, Sager M, Fraifeld S.

Alzheimers Dement. 2010 Nov;6(6):475-81. doi: 10.1016/j.jalz.2010.10.001.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias